Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
B-LYMPHOCYTE chemoattractant (...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
B-LYMPHOCYTE chemoattractant (BLC/CXCL13): A potential novel disease activity marker of rheumatoid arthritis
Bibliographic Details
Main Authors:
Pastor, I
,
Dickson, M
,
Binks, M
,
Lukey, P
,
Petavy, F
,
McClinton, C
,
Larche, M
,
Taylor, P
Format:
Conference item
Published:
2007
Holdings
Description
Similar Items
Staff View
Similar Items
Between-group differences in ultrasonographic measures of synovitis and kinetics of response to oral steroids in active RA
by: Larche, M, et al.
Published: (2006)
Quantitative power Doppler ultrasonography is a sensitive measure of metacarpophalangeal joint synovial vascularity in rheumatoid arthritis and declines significantly following a 2-week course of oral low-dose corticosteroids.
by: Larché, M, et al.
Published: (2010)
Does serum B lymphocyte chemoattractant protein13 (CXCL13) level correlate with parameters of disease activity and severity in rheumatoid arthritis? Clinical and musculoskeletal ultrasonographic assessment
by: Eman A. Baraka, et al.
Published: (2020-11-01)
Retraction Note: Does serum B lymphocyte chemoattractant protein13 (CXCL13) level correlate with parameters of disease activity and severity in rheumatoid arthritis? Clinical and musculoskeletal ultrasonographic assessment
by: Eman A. Baraka, et al.
Published: (2022-01-01)
Ultrasonographic measures of synovitis in an early phase clinical trial: a double-blind, randomised, placebo and comparator controlled phase IIa trial of GW274150 (a selective inducible nitric oxide synthase inhibitor) in rheumatoid arthritis.
by: Seymour, M, et al.
Published: (2012)